cardiovascular benefits of glp 1 agonists GLP-1 receptor agonists: The beyond glucose control Cardiovascular Effects of Glucagon-Like Peptide-1

Lancet 2021;397:97184.ArticlePubMed 48

There are no ongoing or planned clinical studies addressing the role of tirzepatide in CKD

4e693e702

doi: 10.1097/MED.0000000000000798

At Cost Plus Drugs, our commitment to transparent drug pricing has always been unwavering, and with clinical leaders in obesity like 9amHealth, we are dedicated to providing affordable and accessible healthcare solutions for patients with cardiometabolic conditions." Paul Geevarghese, COO and co-founder of 9amHealth, said in the same press release, Our collaboration with Mark Cuban Cost Plus Drugs gives employers a way to provide expert medical management of obesity, without the massive price tag

This indicates that when evaluating the efficacy of different GLP-1RA drugs, varying treatment durations should be employed to fully reflect the therapeutic potential of each drug